Effects of the neuroprotective agent riluzole on the high voltage- activated calcium channels of rat dorsal root ganglion neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1280-1290

  Huang, Chao Sheng ^a   Song, Jin Ho ^a   Nagata, Keiichi ^a   Yeh, Jay Z ^a   Narahashi, Toshio ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL BLOCKING AGENT; GLUTAMIC ACID; NIMODIPINE; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; RILUZOLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CALCIUM CURRENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; NERVE CELL NECROSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SEDATION; SPINAL GANGLION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SPINAL; NEUROPROTECTIVE AGENTS; NIMODIPINE; RATS; RATS, SPRAGUE-DAWLEY; RILUZOLE; THIAZOLES;

EID: 0030886021     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. AOSAKI, T. AND KASAI, H.: Characterization of two kinds of high-voltage-activated Ca-channel currents in chick sensory neurons. Pflügers Arch. 414: 150-156, 1989.
2. BENOIT, E. AND ESCANDE, D.: Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflügers Arch. 419: 603-609, 1991.
3. BENSIMON, G., LACOMBLEZ, L., MEININGER, V. AND ALS/RILUZOLE STUDY GROUP: A controlled trial of riluzole in amyotrophic lateral sclerosis. N. Engl. J. Med. 330: 585-591, 1994.
4. BICKMEYER, U., MULLER, E. AND WIEGAND, H.: Development of calcium currents in cultures of mouse spinal cord and dorsal root ganglion neurons. NeuroReport 4: 131-134, 1993.
5. BOENING, J. A., KASS, I. D., COTTRELL, J. E. AND CHAMBERS, G.: The effect of blocking sodium influx on anoxic damage in the rat hippocampal slice. Neuroscience 33: 263-268, 1989.
6. BOIREAU, A., BORDIER, F., DUBJDAT, P. AND DOBLE, A.: Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission. Neurosci. Lett. 195: 9-12, 1995.
7. BRYSON, H. M., FULTON, B. AND BENFIELD, P.: Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drug Eval. 52: 549-563, 1996.
8. CHOI, D. W. AND ROTHMAN, S. M.: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13: 171-182, 1990.
9. DEBONO, M.-W., LE GUERN, J., CANTON, T., DOBLE, A. AND PRADIER, L.: Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 235: 283-289, 1993.
10. DISTERHOFT, J. F., MOYER, J. R. JR., THOMPSON, L. T. AND KOWALSKA, M.: Functional aspects of calcium-channel modulation. Clin. Neuropharmacol. 16: suppl. 1, S12-S24, 1993.
11. 3H]aspartate release from cultured cerebellar granule cells. Neurosci. Lett. 140: 251-254, 1992.
12. DUTAR, P., RASCOL, O. AND LAMOUR, Y.: ω-Conotoxin GVIA blocks synaptic transmission in the CA1 field of the hippocampus. Eur. J. Pharmacol. 174: 261-266, 1989.
13. ELLINOR, P. T., ZHANG, J.-F., RANDALL, A. D., ZHOU, M., SCHWARZ, T. L., TSIEN, R. W. AND HORNE, W. A.: Functional expression of a rapidly inactivating neuronal calcium channel. Nature (Lond.) 363: 455-458, 1993.
14. FOX, A. P., NOWYCKY, M. C. AND TSIEN, R. W.: Single-channel recordings of three types of calcium channels in chick sensory neurones. J. Physiol. (Lond.) 394: 173-200, 1987.
15. GOLDMAN, D. E.: Potential, impedance and rectification in membranes. J. Gen. Physiol. 27: 37-60, 1943.
16. GRABNER, M., WANG, Z., HERING, S., STRIESSNIG, J. AND GLOSSMAN, H.: Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron 16: 207-218, 1996.
17. HAMILL, O. P., MARTY, A., NEHER, E., SAKMANN, B. AND SIGWORTH, F. J.: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100, 1981.
18. HEBERT, T., DRAPEAU, P., PRADIER, L. AND DUNN, R. J.: Block of the rat brain IIA sodium channel α subunit by the neuroprotective drug riluzole. Mol. Pharmacol. 43: 1055-1060, 1994.
19. 2+ channels. Neuron 9: 69-77, 1992.
20. HODGKIN, A. L. AND KATZ, B.: The effect of sodium ions on the electrical activity of the giant axon of the squid. J. Physiol. (Lond.) 108: 37-77, 1949.
21. HUANG, C.-S., SONG, J.-H., NAGATA, K., TWOMBLY, D., YEH, J. Z. AND NARAHASHI, T.: G proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons. Brain Res., in press, 1997.
22. HUBERT, J. P., DELUMEAU, J. C., GLOWINSKI, J., PRJMONT, J. AND DOBLE, A.: Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br. J. Pharmacol. 113: 261-267, 1994.
23. KOSTYUK, P., PRONCHUK, N., SAVCHENKO, A. AND VERKHRATSKY, A.: Calcium currents in aged dorsal root ganglion neurones. J. Physiol. (Lond.) 461: 467-483, 1993.
24. LACOMBLEZ, L., BENSIMON, G., LEIGH, P. N., GUILLET, P. AND MEININGER, V.: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347: 1425-1431, 1996.
25. LÉVÊQUE, C., FAR, O. E., MARTIN-MOUTOT, N., SATO, K., KATO, R., TAKAHASHI, M. AND SEAGAR, M. J.: Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicles exocytosis. J. Biol. Chem. 268: 6306-6312, 1994.
26. 2+ channel. Eur. J. Pharmacol. 206: 61-68, 1991.
27. MALGOURIS, C., BARDOT, F., DANIEL, M., PELLIS, F., RATAUD, J., UZAN, A., BLANCHARD, J. C. AND LADURON, P. M.: Riluzole, a novel antiglutamate, prevent memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci. 9: 3720-3727, 1989.
28. MALGOURIS, C., DANIEL, M. AND DOBLE, A.: Neuroprotective effects of riluzole on N-methyl-D-aspartate-or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci. Lett. 177: 95-99, 1994.
29. MARTIN, D., THOMPSON, M. A. AND NADLER, J. V.: The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur. J. Pharmacol. 250: 473-476, 1993.
30. 2+ currents, postinhibitory rebound, and postspike afterhyperpolarization in lamprey neurons. J. Neurophysiol. 70: 2606-2619, 1993.
31. MCCLESKEY, E. W., FOX, A. P., FELDMAN, D. H., CRUZ, L. J., OLIVERA, B. M., TSIEN, R. W. AND YOSHIKAMI, D.: ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci. U.S.A. 84: 4327-4331, 1987.
32. MELDRUM, B.: Excitatory amino acids and anoxic/ischaemic brain damage. Trends Neurosci. 8: 47-48, 1985.
33. MINTZ, I. M. AND BEAN, B. P.: Block of calcium channels in rat neurons by synthetic ω-Aga-IVA. Neuropharmacology 32: 1161-1169, 1993.
34. MINTZ, I. M., VENEMA, V. J., SWIDEREK, K. M., LEE, T. D., BEAN, B. P. AND ADAMS, M. E.: P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature (Lond.) 355: 827-829, 1992a.
35. MINTZ, I. M., ADAMS, M. E. AND BEAN, B. P.: P-type calcium channels in rat central and peripheral neurons. Neuron 9: 85-95, 1992b.
36. 2+ current in hippocampal CA3 neurons. Neuron 10: 327-334, 1993.
37. NOWYCKY, M. C., FOX, A. P. AND TSIEN, R. W.: Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644. Proc. Natl. Acad. Sci. U.S.A. 82: 2178-2182, 1985.
38. OHMORI, H. AND YOSHII, M.: Surface potential reflected in both gating and permeation mechanisms of sodium and calcium channels of the tunicate egg cell membrane. J. Physiol. (Lond.) 267: 429-463, 1977.
39. PRATT, J., RATAUD, J., BARDOT, F., Roux, M., BLANCHARD, J. C., LADURON, P. M. AND STUZMANN, J. M.: Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia. Neurosci. Lett. 140: 225-230, 1992.
40. PRENEN, G. H. M., GWAN, G. K., POSTEMA, F., ZUIDERVEEN, F. AND KORF, J.: Cerebral cation shifts in hypoxic-ischemic brain damage are prevented by the sodium channel blocker tetrodotoxin. Exp. Neurol. 99: 118-132, 1988.
41. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 15: 2995-3012, 1995.
42. 2+ channels in cerebellar granule cells. Soc. Neurosci. Abstr. 19: 1478, 1993.
43. 2+ channels in rat central and peripheral neurons: high-threshold current resistant to dihydropyridine blockers and ω-conotoxin. Neuron 6: 269-280, 1991.
44. ROMETTINO, S., LAZDUNSKI, M. AND GOTTESMANN, C.: Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy. Eur. J. Pharmacol. 199: 371-373, 1991.
45. ROTHMAN, S.: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4: 1884-1891, 1984.
46. ROTHMAN, S. M. AND OLNEY, J. W.: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19: 105-111, 1986.
47. ROTHSTEIN, J. D. AND KUNCL, R. W.: Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65: 643-651, 1995.
48. RUSIN, K. I. AND MOISES, H. C.: μ-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons. J. Neurosci. 15: 4315-4327, 1995.
49. 1 subunits. Neuron 11: 291-303, 1993.
50. SONG, J.-H., NAGATA, K., YEH, J. Z. AND NARAHASHI, T.: Effects of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. Soc. Neurosci. Abstr. 22: 59, 1996.
51. STUTZMANN, J.-M., BÖHME, G. A., GANDOLFO, G., GOTTESMANN, C., LAFFORGUE, J., BLANCHARD, J.-C., LADURON, P. M. AND LAZDUNSKI, M.: Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat. Eur. J. Pharmacol. 193: 223-229, 1991.
52. 2+ channels in supporting hippocampal synaptic transmission. Science 264: 107-111, 1994.
53. YAMASAKI, Y., KOGURE, K., HARA, H., BAN, H. AND AKAIKE, N.: The possible involvement of tetrodotoxin-sensitive ion channels in ischemic neuronal damage in the rat hippocampus. Neurosci. Lett. 121: 251-254, 1991.
54. YOSHII, M., TSUNOO, A. AND NARAHASHI, T.: Gating and permeation properties of two types of calcium channels in neuroblastoma cells. Biophys. J. 54: 885-895, 1988.
55. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 32: 1075-1088, 1993.